Our Blog

Victims of AndroGel Heart Attacks Fight Back

heart_167202284Everything You Need to Know About Testosterone Injury Lawsuits

When your doctor prescribed testosterone replacement drugs, you assumed he was recommending a medication that had minimal side effects was the standard treatment for your age-related low-T. You didn’t know that the drugs you took were only approved to treat low testosterone levels caused by a medical condition. You didn’t know that low-t is a manufactured condition invented by the drug companies to advertise and sell testosterone products. And, you didn’t know that the drugs could have serious, and even fatal, effects.

In January 2014, the U.S. Food and Drug Administration (FDA) announced that it was investigating the risk of stroke, heart attack, and death in men who were prescribed testosterone therapy drugs like AndroGel and Axiron. This announcement was made after several scientific studies found a link between the drugs and risk of cardiovascular problems, such as stroke, heart attack, pulmonary embolism and deep vein thrombosis. As a result, the FDA ordered the drug companies to stop marketing the drug for off-label uses.

Now, more than 2,000 men filed lawsuits alleging that they had suffered serious cardiovascular events after taking testosterone drugs to treat low-T. These men the drug companies wrongly advertised testosterone products as safe and effective treatment for general symptoms such as fatigue, low sex drive, depression, and weight gain– although the medication was not approved for age-related low-T. They are also claiming that manufacturers overstated the benefits of the drugs, but didn’t inform patients and their doctors about the potential risks.

Multidistrict Litigation

In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all federal cases involving injury from testosterone replacement therapy drugs. All two thousand plus cases will be heard by District Judge Matthew Kennelly in the Northern District of Illinois.

It isn’t easy to fight a case against a big drug company. Drug companies have teams of lawyers who can work around the clock. Individuals can hire attorneys, but studying medical records, collecting evidence, and hiring expert witnesses is expensive and time consuming. One person cannot have access to al the resources needed to defeat the drug companies.

Multidistrict litigation evens the playing field. One judge hears all cases, so the judge doesn’t need to hear separate but duplicate depositions for each case. Instead, evidence from one lawsuit can be used for other applicable litigation. This allows plaintiffs to pool the resources that apply to all cases, including medical witnesses and legal research. Individual lawyers can act as a team, evening the odds and saving time and money.

What’s a Bellwether Case?

It can take years to try two thousand lawsuits. A bellwether trial is a sample trial. It allows both the plaintiffs and the defendants to test arguments on a small scale. The goal is to move towards the eventual resolution of all cases. The results of a bellwether trial are often used to determine if it is more beneficial to settle than to pursue further litigation.

Each side recommends cases for bellwether hearing. Although litigation has been filed against the makers of Axiron, Testim, AndroDerm, Depo-Testosterone, Delatestryl, and Fortesta, most of the lawsuits have been filed against AbbVie, the manufacturer of AndroGel. Because AbbVie is named in the majority of cases, the bellwether trials will only include cases involving AndroGel. The cases will be split into two categories: cases involving heart attacks and cases involving blood clots, including thromboembolism and deep vein thrombosis.

Eight cases will be chosen by the end of August. The first series of trials will begin in 2016.

Drug Companies Ask to Have Claims Dismissed

The drug companies know that they can’t win. But, they will do everything they can to minimize the amount they will have to pay. On July 6, AbbVie filed a motion asking that 169 cases be dismissed. According to the drug maker, these cases are missing necessary information. In most cases, the missing information is permission for AbbVie to collect additional medical records. AbbVie would like to access medical records to find potential weaknesses in AndroGel injury claims

The Drug Safety Lawyers Fight the Big Drug Companies

AbbVie has teams of lawyers who are fighting to hold on to every penny. If you want a fair chance, you need an attorney who fights harder.

Each of our attorneys more than twenty five years of experience in personal injury law. We’ve taken on the big drug companies and gotten real results. If you suffered a heart attack, stroke or blood clot after using AndroGel or other testosterone products, you deserve accountability. We can help. Call 888-808-1340 to schedule your free consultation.



This is a unique website which will require a more modern browser to work! Please upgrade today!